Report an error
Spotted something inaccurate in “Debulking Chemotherapy Associated with 79% Response Rate to Teclistamab After Overcoming Hi-MM Resistance in Multiple Myeloma”? Tell us what’s wrong and we’ll check it against the original source.
This form is for factual corrections. We read every report but cannot reply individually.